{
    "clinical_study": {
        "@rank": "141365", 
        "arm_group": [
            {
                "arm_group_label": "Remifentanil\uff0cmidazolam", 
                "arm_group_type": "Experimental", 
                "description": "Remifentanil 1\u00b5g/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h  continuous intravenous pump for 7days or extubation"
            }, 
            {
                "arm_group_label": "Fentanyl\uff0cmidazolam", 
                "arm_group_type": "Experimental", 
                "description": "Fentanyl  1\u00b5g/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h  continuous intravenous pump  for 7days or extubation"
            }, 
            {
                "arm_group_label": "Normal saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Normal saline1\u00b5g/kg/hr intravenous pump and Midazolam loading dose 0.05mg/kg followed by 0.02~0.1mg/kg/h continuous intravenous pump for 7days or extubation"
            }
        ], 
        "brief_summary": {
            "textblock": "Benzodiazepines is a commonly uesd sedative medication,there are many reports  that\n      Benzodiazepines is associated with delirium ,but using of analgesia reduces benzodiazepines\n      requirements .The purpose of this study is to determine whether analgesia based sedation\n      protocol  reduces the incident of delirium."
        }, 
        "brief_title": "The Effect of Analgesia Based Sedation Protocol on Brain Function on Critical Care Patients", 
        "condition": "Delirium", 
        "condition_browse": {
            "mesh_term": "Delirium"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signing a consent form\n\n          -  postoperative patient\n\n          -  Requirement for mechanical ventilation and anticipate time of mechanical ventilation\n             more than 24 hours\n\n          -  Requirement for  sedation\n\n          -  Age more than 18  and less  than 85 years old\n\n        Exclusion Criteria:\n\n          -  Unstable blood circulation\n\n          -  Heart rate less than 50  beats per minute\n\n          -  II \u00b0 \uff5e III \u00b0 atrioventricular conduct block\n\n          -  Intracranial lesions  \u3001neurosurgical intervention  and  mental disability inability\n             to cooperate;\n\n          -  Receipt of antipsychotics \u3001hypnotic drugs before  surgery ;\n\n          -  Alcohol abuse;\n\n          -  Liver failure class Child-Pugh C;\n\n          -  Acute Respiratory Distress Syndrome;\n\n          -  Acute or chronic renal failure;\n\n          -  Other severe diseases ,septic shock;\n\n          -  Receipt of neuromuscular blocking  drug;\n\n          -  Pregnancy and nursing woman;\n\n          -  Allergy to investigational drug or  other contraindication."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02078583", 
            "org_study_id": "PEKING  SEDATION"
        }, 
        "intervention": [
            {
                "arm_group_label": "Fentanyl\uff0cmidazolam", 
                "intervention_name": "Fentanyl", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Remifentanil\uff0cmidazolam", 
                "intervention_name": "Remifentanil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Normal saline", 
                "intervention_name": "Normal saline", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Midazolam", 
                "Fentanyl", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 4, 2014", 
        "number_of_arms": "3", 
        "overall_contact": {
            "email": "fancyjuice@126.com", 
            "last_name": "Dan Liu, Resident physician", 
            "phone": "+8613811365572"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The incidence and  duration of delirium  in patients with different regimens", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02078583"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Mortality", 
                "safety_issue": "No", 
                "time_frame": "28 days"
            }, 
            {
                "measure": "Ventilator-free days", 
                "safety_issue": "No", 
                "time_frame": "an expected average of 7 days"
            }, 
            {
                "measure": "Mean days of mechanical ventilation", 
                "safety_issue": "No", 
                "time_frame": "an expected average of 7 days"
            }, 
            {
                "measure": "Length of  ICU stay", 
                "safety_issue": "No", 
                "time_frame": "an expected average of 7 days"
            }, 
            {
                "description": "Analgesic level\u3001sedation level\u3001brain function\u3001 blood perfusion for peripheral and brain circulation\u3001sleep stages and variation of blood volume", 
                "measure": "Index of anesthesia depth monitoring", 
                "safety_issue": "No", 
                "time_frame": "From admission to ICU to weaning,about 7 days"
            }, 
            {
                "measure": "Infusion velocity and total dose of sedative drugs  in different  groups", 
                "safety_issue": "No", 
                "time_frame": "From admission to  ICU to  extubation or drug withdrawal,about 7 days"
            }, 
            {
                "measure": "Plasma melatonin  level", 
                "safety_issue": "No", 
                "time_frame": "Every 6 hours during the next ICU day"
            }, 
            {
                "measure": "Total rescue dose of midazolam", 
                "safety_issue": "No", 
                "time_frame": "Seven days after giving  midazolam to patient"
            }, 
            {
                "measure": "Variations of HR\u3001RR\u3001BP\u3001SpO2", 
                "safety_issue": "No", 
                "time_frame": "an expected average of 7 days"
            }
        ], 
        "source": "Peking University People's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University People's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}